CD11a, Rat Antibody from MILTENYI BIOTEC B.V. & Co. KG
Search, find, compare suppliers for anti-CD11a, Rat antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | CD11a, Rat |
| Clone | REA596 |
| Host Species | Recombinant Human |
| Reactive Species | rat |
| Isotype | IgG1 |
| Format | PE-Vio 770 conjugate |
| Size | 30 µg in 1 mL |
| Concentration | 1:10 |
| Applications | Flow cytometry |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | CD11a Antibody, anti-rat, PE-Vio® 770, REAfinity™. Clone REA596 recognizes the rat CD11a antigen, a single-pass type I membrane protein, also known as integrin α-L (ITGAL). Integrins are heterodimeric adhesion molecules comprised of α- and β-subunits that participate in immune cell interactions as well as in immune cell-extracellular matrix interactions. CD11a combines with CD18 (ITGB2) to form the integrin lymphocyte function-associated antigen-1 (LFA-1), which is expressed on all leukocytes. | Additional information: Clone REA596 displays negligible binding to Fc receptors. |
| Immunogen | n/a |
| Other Names | ITGAL, LFA-1, ITGA |
| Gene, Accession # | Gene ID: 308995 |
| Catalog # | 130-109-126 |
| Price | $156 |
| Order / More Info | CD11a, Rat Antibody from MILTENYI BIOTEC B.V. & Co. KG |
| Product Specific References | Tamatani, T. et al. (1991) Characterization of the rat leukocyte integrin, CD11/CD18, by the use of LFA-1 subunit-specific monoclonal antibodies. Eur. J. Immunol. 21 (3): 627-633. | Tamatani, T. et al. (1991) Molecular mechanisms underlying lymphocyte recirculation. II. Differential regulation of LFA-1 in the interaction between lymphocytes and high endothelial cells. Eur. J. Immunol. 21 (3): 855-858. |
MILTENYI BIOTEC B.V. & Co. KG
MILTENYI BIOTEC B.V. & Co. KG
Friedrich-Ebert-StraÃe 68
51429 Bergisch Gladbach GERMANY
P: +49 2204 8306-0
F: +49 2204 85197
macs@miltenyibiotec.de
https://www.miltenyibiotec.com
Profile of MILTENYI BIOTEC B.V. & Co. KG
Return to Antibodies